Intratumoral Injection of Dengue Virus-1 #45AZ5 (PV-001-DV) in Patients With Melanoma

NCT03989895 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Melanoma

Interventions

BIOLOGICAL: Dengue Virus-1 #45AZ5 (PV-001-DV)

Sponsor

PrimeVax Immuno-Oncology Inc.

Collaborators

[object Object]